NCT04407819 (SARCoDM) is a clinical trial of WHOLE BODY DXA in Sarcopenia, sponsored by Dionyssiotis, Yannis, M.D..

Who is sponsoring NCT04407819?

NCT04407819 is sponsored by Dionyssiotis, Yannis, M.D..

What drugs are being tested in NCT04407819?

Interventions in NCT04407819: WHOLE BODY DXA.

What condition does NCT04407819 study?

NCT04407819 studies Sarcopenia.

Is NCT04407819 still recruiting?

NCT04407819 is currently completed. Last updated 29 May 2020.

Last reviewed 2020-05-29 · How we verify

NCT04407819: SARCoDM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sarcopenia and Diabetes Mellitus

Completed Last updated 29 May 2020

What this trial tests

trial testing WHOLE BODY DXA in Sarcopenia in 50 participants. Completed in 22 September 2018.

Timeline

20 March 2018

Primary endpoint
31 July 2018

22 September 2018

Quick facts

Lead sponsor	Dionyssiotis, Yannis, M.D.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	50
Start date	20 March 2018
Primary completion	31 July 2018
Estimated completion	22 September 2018
Sites	1 location across Greece

Drugs / interventions tested

WHOLE BODY DXA

Conditions studied

Sarcopenia — all drugs for Sarcopenia →

Sponsor

Dionyssiotis, Yannis, M.D.

Who can join

Adults 20 to 80, any sex, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The association of diabetes mellitus type 2 (T2DM) with sarcopenia has not been adequately investigated. Sarcopenia is characterized by progressive and generalized loss of skeletal muscle mass which may affect performance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting

Other Dionyssiotis, Yannis, M.D. trials

Trials by the same sponsor.

NCT03863379 — Sarcopenic Obesity in Neurodisabilities · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04407819 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dionyssiotis, Yannis, M.D.
Last refreshed: 29 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04407819.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing